Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Omipalisib emerged victorious in a screen of hundreds of longevity-enhancing mTOR inhibitors, achieving one of the largest pharmacological lifespan extensions in worms to date. Discovered and launched by Rapamycin Longevity Labs
| $342.12% | |
| $10.07% | |
| $10.07% | |
| $0.470.03% | |
| $0.400.02% | |
| $0.310.02% | |
| $0.270.02% | |
| $0.270.02% | |
| $0.240.01% | |
| $0.220.01% | |
| $0.020.00% | |
| $0.010.00% |